Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.

ClinicalTrials.gov ID: NCT00269828

Public ClinicalTrials.gov record NCT00269828. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 8:48 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Paclitaxel Poliglumex (CT-2103) vs. Paclitaxel for the Treatment of Women With Chemotherapy-Naïve Advanced Non-Small Cell Lung Cancer (NSCLC) Who Are Performance Status 2.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a randomized, open-label, multinational, phase III study in women with histologically- or cytologically-confirmed advanced NSCLC who are chemotherapy naïve and have PS 2. Study drug will be administered on day 1 of each 21 day cycle

Study identification

NCT ID
NCT00269828
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
CTI BioPharma
Industry
Enrollment
600 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2005 (Type not available)
Primary completion
Not listed
Completion
Dec 2006 (Type not available)
Last update posted
Nov 24, 2020

2005 – 2006

United States locations

U.S. sites
64
U.S. states
23
U.S. cities
60
Facility City State ZIP Site status
Desert Oasis Cancer Center Casa Grande Arizona 85222 —
Arizona Hematology Oncology Tucson Arizona 85704 —
Genesis Cancer Center Hot Springs Arkansas 71913 —
Heritage Physician Group, Oncology Hot Springs Arkansas 71913 —
Pacific Cancer Medical Center, Inc Anaheim California 92801 —
Comprehensive Blood and Cancer Center Bakersfield California 93309 —
Tower Cancer Research Foundation Beverly Hills California 90211 —
Providence St. Joseph Medical Center Burbank California 91505 —
Hematology/Oncology Group of Fresno, Inc Fresno California 93720 —
Comprehensive Cancer Center-Research Office Glendale California 91204 —
Loma Linda University Cancer Institute Loma Linda California 92354 —
Pacific Shores Medical Group Long Beach California 90813 —
Medical Oncology Care Associates Orange California 92868 —
The Cancer Research and Prevention Center Soquel California 95073 —
Bethesda Research Center Boynton Beach Florida 33435 —
Broward Oncology Associates Fort Lauderdale Florida 33308 —
Florida Wellcare Inverness Florida 34452 —
Cancer & Blood Disease Center Lecanto Florida 34461 —
Oncology-Hematology Associates of West Broward Tamarac Florida 33321 —
Hematology Oncology Speaclist Tampa Florida 33607 —
Joliet Oncology Hematology Associates, Ltd. Joliet Illinois 60435 —
Loyola University Health Systems Maywood Illinois 60153 —
Mid-Illinois HEM & ONC Assoc. Normal Illinois 61761 —
Northern Indiana Cancer Research Consortium South Bend Indiana 46601 —
Associated Physicians & Surgeons Clinic Terre Haute Indiana 47804 —
Kentucky Cancer Clinic Hazard Kentucky 41701 —
West Kentucky Hematology & Oncology Group, PSC Paducah Kentucky 42003 —
Cabrini Center for Cancer Care Alexandria Louisiana 71301 —
West Michigan Cancer Center Kalamazoo Michigan 49007 —
Oncology Care Associates, PLLC Saint Joseph Michigan 49085 —
Not listed Troy Michigan 48085 —
Hubert H. Humphrey Cancer Center Robbinsdale Minnesota 55422 —
St. Louis Cancer Care Center Chesterfield Missouri 63017 —
Columbia Comprehensive Cancer Care Clinics Columbia Missouri 65201 —
Bond Clinic Rolla Missouri 65401 —
Saint Louis University St Louis Missouri 63110 —
Washington University Siteman Cancer Center Pharmacy St Louis Missouri 63110 —
Montana Cancer Specialists Missoula Montana 59802 —
Sierra Nevada Oncology Care Carson City Nevada 89100 —
Essex Oncology of North Jersey, PA Belleville New Jersey 07109 —
Atlanta HEM ONC Manasquan New Jersey 08736 —
Oncology and Hematology Specialist, PA Mountain Lakes New Jersey 07046 —
San Juan Oncology Association Farmington New Mexico 87401 —
Suny Downstate Medical Center Brooklyn New York 11203 —
Cancer Treatment Services Corning New York 14830 —
Interlakes Foundation, Inc. Rochester New York 14623 —
Guthrie Clinic Sayre New York 18840 —
Our Lady of Mercy Medical Center The Bronx New York 10466 —
New York Medical Collegw Valhalla New York 10595 —
Alamance Cancer Center Burlington North Carolina 27215 —
UNC Chapel Hill Oncology Protocol Office Chapel Hill North Carolina 27599 —
Leo Jenkins Cancer Center Greenville North Carolina 28734 —
Northwestern Carolina Oncology & Hematology Hickory North Carolina 28602 —
St. Alexius Medical Center Bismarck North Dakota 58501 —
University of Cleveland Cleveland Ohio 44106 —
Metro Health Medical Center Cleveland Ohio 44109 —
The Cleveland Clinic Foundation, Taussig Cancer Center Cleveland Ohio 44195 —
Dayton Clinical Oncology Program Dayton Ohio 45429 —
Signal Point Hematology/Oncology, Inc. Middletown Ohio 45042 —
Charleston Hematology Oncology Charleston South Carolina 29403 —
The Family Cancer Center Collierville Tennessee 38077 —
Mary Crowley Medical Research Center Dallas Texas 75201 —
JPS Center for Cancer Care Fort Worth Texas 76104 —
Columbia Basin HEM/ONC Kennewick Washington 99336 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 79 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00269828, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 24, 2020 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00269828 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →